Hauptman-Woodward Medical Research Institute Inc
- Assets
- $26.1m
- Revenue
- $9.4m
- Investments
- $0.0
- Employees
- 35
- Location
- Buffalo, NY
- Founding
- 12/1957
- Data as of
- 10/2021
- EIN
- 16-0807558
Organization Overview
Hauptman-Woodward Medical Research Institute Inc is located in Buffalo, NY. The organization was established in 1957. According to its NTEE Classification (H20) the organization is classified as: Birth Defects & Genetic Diseases Research, under the broad grouping of Medical Research and related organizations. As of 10/2021, Hauptman-Woodward Medical Research Institute Inc employed 35 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Hauptman-Woodward Medical Research Institute Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 10/2021, Hauptman-Woodward Medical Research Institute Inc generated $9.4m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 9.3% each year. All expenses for the organization totaled $6.9m during the year ending 10/2021. While expenses have increased by 2.0% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
GUIDED BY ITS MOTTO, CURE-OSITY, THE HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE (HWI) CREATES NOVEL STRATEGIES AND TECHNOLOGIES TO PROMOTE THE UNDERSTANDING, PREVENTION, AND TREATMENT OF MANY HUMAN DISEASES. HWI SCIENTISTS CONDUCT BASIC, FUNDAMENTAL RESEARCH THAT WILL PROVIDE THE FOUNDATION FOR EFFECTIVE THERAPEUTIC APPROACHES FAR INTO THE FUTURE. OFTEN OUR RESEARCH INCLUDES IDENTIFYING PROTEINS INVOLVED IN DISEASE WHICH ALLOWS TREATMENTS TO BE MORE EFFECTIVE BY TARGETING THOSE PROTEINS. EXAMPLES OF CURRENT PROJECTS INCLUDE BREAST CANCER, PROSTATE CANCER, MULTIPLE MYELOMA, STUDYING THE EFFECT OF GRAVITY ON CELLS, AND BIOLOGICAL CELL STRUCTURE DETERMINATION FOR NEARLY ALL DISEASE THROUGH THE USE OF HARD X-RAY FREE ELECTRON LASERS (XFELS) AND HIGH-THROUGHPUT CRYSTALLIZATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE NATIONAL SCIENCE FOUNDATION BIOXFEL SCIENCE & TECHNOLOGY CENTER WATCHED BIMOLECULAR MACHINES AT WORK USING X-RAY LASERS, TO BETTER UNDERSTAND HOW LIFE WORKS AT THE MOLECULAR LEVELS, TO UNDERSTAND HOW THESE MOLECULAR MACHINES SUPPORT LIFE ON EARTH TO INVENT, DISCOVER, DEVELOP AND PROVIDE NEW TOOLS AN TRAINING FOR THE WIDER SCIENTIFIC COMMUNITY.
IMCA-CAT PROVIDED AN OUTSTANDING SUPPORT ENVIRONMENT FOR MACRO-MOLECULAR CRYSTALLOGRAPHY BY DEVELOPING AND OPERATING AN EFFICIENT, RELIABLE , HIGH-THROUGHPUT FACILITY AT WHICH BOTH CONFIDENTIAL AND PROPRIETARY EQUIPMENT CAN BE READILY AND EASILY ACCOMMODATED.
THE PROJECT AIMS TO IMPLEMENT A MODERN INTERNET INTERFACE FOR USERS OF THE HIGH-THROUGHPUT CRYSTALLIZATION SCREENING CENTER TO INTERACT WITH THE IMAGES OF THEIR CRYSTALLIZATION SCREENING EXPERIMENTS. A FURTHER GOAL IS TO BEGIN DEVELOPMENT OF SOFTWARE TO ENABLE AUTOMATIC IMAGE ANALYSIS AND CLASSIFICATION.
OTHER PROGRAM SERVICES INCLUDE VARIOUS RESEARCH WORK UNDERTAKEN IN ENDOCRINE BIOCHEMISTRY AND MOLECULAR BIOPHYSICS TO DEVELOP AND UNDERSTAND THE CAUSE OF DISEASE AND POTENTIAL THERAPIES FOR THE CURE. EXPENSES $5,956,273 INCLUDE GRANTS OF $0 AND REVENUE OF $477,899.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Lisa Keefe VP | Officer | 37.5 | $201,583 |
Edward Snell Board Member/president & CEO | OfficerTrustee | 37.3 | $142,298 |
Anne Kent Chief Financial Officer | Officer | 37.3 | $134,776 |
Jill Szczesek Chief Operating Officer (to February 2021) | Officer | 37.3 | $127,692 |
Daniel Gewirth Board Member/principal Research Scientist | Trustee | 37.5 | $123,104 |
Jill Bond Board Member/secretary | OfficerTrustee | 0.2 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $83,681 |
| Government grants | $2,690,724 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,271,830 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $6,046,235 |
| Total Program Service Revenue | $2,204,345 |
| Investment income | $162,943 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $427,784 |
| Net Gain/Loss on Asset Sales | $517,784 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $9,359,091 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $878,670 |
| Compensation of current officers, directors, key employees. | $168,418 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,333,965 |
| Pension plan accruals and contributions | $55,676 |
| Other employee benefits | $210,018 |
| Payroll taxes | $124,306 |
| Fees for services: Management | $5,413 |
| Fees for services: Legal | $41,681 |
| Fees for services: Accounting | $56,884 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $74,306 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $317,245 |
| Travel | $1,011 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $48,599 |
| Interest | $218,908 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,329,059 |
| Insurance | $57,421 |
| All other expenses | $136,820 |
| Total functional expenses | $6,944,091 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $81,332 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $2,045,261 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $66,732 |
| Net Land, buildings, and equipment | $14,359,786 |
| Investments—publicly traded securities | $9,336,840 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $211,818 |
| Total assets | $26,101,769 |
| Accounts payable and accrued expenses | $434,239 |
| Grants payable | $0 |
| Deferred revenue | $576,453 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $5,251,122 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $6,261,814 |
| Net assets without donor restrictions | $15,147,665 |
| Net assets with donor restrictions | $4,692,290 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $26,101,769 |
Grants Recieved
Over the last fiscal year, we have identified 5 grants that Hauptman-Woodward Medical Research Institute Inc has recieved totaling $50,527.
| Awarding Organization | Amount |
|---|---|
Community Foundation For Greater Buffalo Inc Buffalo, NY PURPOSE: UNRESTRICTED USE; ANNUAL APPEAL; CANCER RESEARCH AND EDUCATION; IN MEMORY OF | $33,991 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $10,000 |
Edward H Butler Foundation Buffalo, NY PURPOSE: GENERAL FUND | $5,000 |
Baird Foundation Buffalo, NY PURPOSE: UNRESTRICTED | $1,500 |
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $36 |
Endowment Analysis
| Beg. Balance | $2,318,069 |
| Earnings | $507,118 |
| Net Contributions | $210 |
| Other Expense | $507,118 |
| Ending Balance | $2,318,279 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
The National Hemophilia Foundation New York, NY | $46,786,068 | $26,439,522 |
The Foundation For Embryonic Competence Inc Basking Ridge, NJ | $27,223,706 | $15,272,541 |
Hauptman-Woodward Medical Research Institute Inc Buffalo, NY | $26,101,769 | $9,359,091 |
Fshd Society Randolph, MA | $6,079,315 | $3,508,920 |
Hearing Health Foundation New York, NY | $12,344,240 | $5,730,095 |
Center For Human Genetics Inc Cambridge, MA | $9,835,244 | $2,410,975 |
Hereditary Disease Foundation New York, NY | $15,507,063 | $4,059,819 |
Cerebral Palsy Alliance Research Foundation New York, NY | $1,906,191 | $2,233,194 |
Research Fund For Cystic Fibrosis Inc Oradell, NJ | $1,621,345 | $155,788 |
International Federation Of Ferility Societies Mt Royal, NJ | $613,386 | $443,575 |
Everyone Reading Inc Brooklyn, NY | $262,422 | $247,442 |
Fetal Medicine Foundation Inc Fort Lee, NJ | $116,347 | $189,262 |